NSE:AUROPHARMA
Aurobindo Pharma
- Stock
Last Close
1,229.10
02/05 08:51
Market Cap
772.21B
Beta: 0.48
Volume Today
497.51K
Avg: 2.09M
PE Ratio
25.84
PFCF: −10,376.22
Dividend Yield
0.59%
Payout:0%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 29.89B - | 38.50B 28.78% | 42.09B 9.34% | 50.94B 21.03% | 65.52B 28.61% | 74.73B 14.05% | 83.63B 11.92% | 82.90B 0.87% | 80.33B 3.11% | 91.60B 14.03% | 101.76B 11.09% | |
average payables | 17.01B - | 22.89B 34.55% | 25.08B 9.55% | 25.58B 2.01% | 26.52B 3.69% | 26.11B 1.55% | 26.70B 2.25% | 27.49B 2.96% | 32.87B 19.58% | 41.63B 26.64% | 43.22B 3.81% | |
average receivables | 35.08B - | 44.77B 27.61% | 44.98B 0.46% | 44.50B 1.05% | 53.90B 21.12% | 51.75B 4.00% | 40.56B 21.62% | 40.92B 0.88% | 45.48B 11.16% | 46.42B 2.05% | 52.81B 13.78% | |
book value per share | 88.36 - | 120.80 36.72% | 143.38 18.69% | 199.36 39.04% | 237.08 18.92% | 286.90 21.01% | 374.27 30.45% | 419.43 12.07% | 458.12 9.23% | 509.53 11.22% | 560.15 9.93% | |
capex per share | -13.17 - | -26.84 103.89% | -28.95 7.84% | -26.11 9.80% | -27.40 4.93% | -24.42 10.86% | -31.98 30.94% | -46.16 44.34% | -46.43 0.60% | 60.79 230.92% | 33.76 44.46% | |
capex to depreciation | -2.31 - | -3.99 72.92% | -3.96 0.81% | -2.74 30.79% | -2.40 12.34% | -1.48 38.41% | -1.78 19.93% | -2.40 35.23% | -2.19 8.96% | 2.39 209.21% | 1.19 50.02% | |
capex to operating cash flow | -0.62 - | -0.89 43.47% | -0.52 42.02% | -0.78 51.46% | -0.99 26.46% | -0.33 67.00% | -0.56 72.33% | -0.54 4.22% | -1.14 111.41% | 1.46 228.35% | 0.50 65.73% | |
capex to revenue | -0.06 - | -0.11 80.09% | -0.12 0.56% | -0.09 18.25% | -0.08 11.59% | -0.06 24.63% | -0.08 21.23% | -0.12 51.70% | -0.11 4.53% | 0.12 211.12% | 0.06 49.49% | |
cash per share | 8.35 - | 14.26 70.68% | 8.75 38.65% | 21.17 142.06% | 32.92 55.48% | 48.51 47.34% | 95.93 97.78% | 77.78 18.92% | 111.38 43.20% | 107.97 3.07% | 141.30 30.88% | |
days of inventory on hand | 239.42 - | 242.33 1.22% | 245.66 1.37% | 316.66 28.90% | 303.54 4.14% | 288.69 4.89% | 332.71 15.25% | 271.90 18.28% | 275.08 1.17% | 275.69 0.22% | 295.44 7.16% | |
days payables outstanding | 135.98 - | 149.78 10.15% | 141.15 5.76% | 142.02 0.61% | 112.15 21.03% | 95.42 14.92% | 103.01 7.96% | 97.30 5.55% | 125.12 28.60% | 125.20 0.06% | 117.37 6.25% | |
days sales outstanding | 122.55 - | 131.31 7.15% | 101.67 22.57% | 108.51 6.73% | 113.23 4.35% | 70.38 37.84% | 55.39 21.30% | 69.61 25.66% | 68.80 1.16% | 60.62 11.89% | 66.11 9.06% | |
debt to assets | 0.34 - | 0.30 13.10% | 0.21 30.87% | 0.23 9.17% | 0.26 16.52% | 0.22 17.28% | 0.16 24.74% | 0.10 41.04% | 0.13 37.10% | 0.14 5.73% | 0.17 18.45% | |
debt to equity | 0.86 - | 0.67 22.82% | 0.40 39.83% | 0.41 1.86% | 0.50 22.81% | 0.37 25.26% | 0.25 32.49% | 0.13 47.28% | 0.20 47.62% | 0.21 7.44% | 0.25 19.58% | |
dividend yield | 0.00 - | 0.00 6.49% | 0.01 119.15% | 0.00 50.23% | 0.01 130.63% | 0.00 37.45% | 0.01 48.36% | 0.01 115.11% | 0.00 72.09% | 0.00 99.61% | ||
earnings yield | 0.04 - | 0.05 3.02% | 0.06 27.88% | 0.07 19.83% | 0.05 27.02% | 0.12 129.58% | 0.10 11.66% | 0.07 34.56% | 0.06 6.07% | 0.05 23.39% | 0.05 8.41% | |
enterprise value | 396.25B - | 473.83B 19.58% | 423.90B 10.54% | 382.92B 9.67% | 515.36B 34.59% | 277.46B 46.16% | 518.15B 86.75% | 382.89B 26.10% | 312.44B 18.40% | 684.80B 119.18% | 661.29B 3.43% | |
enterprise value over ebitda | 14.98 - | 14.73 1.73% | 11.87 19.40% | 9.85 17.05% | 12.81 30.13% | 5.64 56.00% | 9.63 70.89% | 8.29 13.99% | 7.82 5.68% | 11.08 41.81% | 10.01 9.67% | |
ev to operating cash flow | 32.04 - | 26.93 15.95% | 12.93 51.99% | 19.59 51.50% | 31.77 62.20% | 6.33 80.07% | 15.57 145.79% | 7.63 50.96% | 13.09 71.50% | 28.13 114.88% | 16.85 40.10% | |
ev to sales | 3.29 - | 3.47 5.51% | 2.89 16.73% | 2.36 18.23% | 2.68 13.40% | 1.22 54.48% | 2.11 72.91% | 1.64 22.34% | 1.27 22.55% | 2.36 86.04% | 2.08 11.72% | |
free cash flow per share | 8.03 - | 3.28 59.19% | 27.07 726.23% | 7.25 73.21% | 0.28 96.09% | 50.35 17,649.91% | 24.83 50.68% | 39.46 58.88% | -5.69 114.43% | -19.24 237.78% | 33.57 274.53% | |
free cash flow yield | 0.01 - | 0.00 66.54% | 0.04 811.52% | 0.01 69.48% | 0.00 97.07% | 0.12 33,941.24% | 0.03 76.88% | 0.06 109.44% | -0.01 118.63% | -0.02 57.19% | 0.03 271.33% | |
graham net net | -41.25 - | -34.63 16.04% | -36.15 4.38% | -28.02 22.51% | -43.30 54.56% | -36.44 15.84% | 17.15 147.05% | 39.75 131.82% | 20.88 47.48% | -6.47 130.98% | 11.65 280.09% | |
graham number | 231.70 - | 303.68 31.06% | 356.21 17.30% | 430.73 20.92% | 464.00 7.72% | 558.46 20.36% | 875.62 56.79% | 653.08 25.42% | 582.34 10.83% | 787.87 35.29% | 868.30 10.21% | |
income quality | 0.57 - | 0.65 13.28% | 1.07 65.73% | 0.60 43.69% | 0.52 13.00% | 1.17 123.08% | 0.45 61.27% | 1.49 228.11% | 0.91 38.58% | 0.77 16.02% | 1.13 46.74% | |
intangibles to total assets | 0.07 - | 0.06 16.02% | 0.06 7.76% | 0.09 55.94% | 0.12 26.01% | 0.11 3.89% | 0.09 18.38% | 0.11 15.59% | 0.10 7.70% | 0.09 8.01% | 0.09 5.87% | |
interest coverage | 32.83 - | 36.10 9.98% | 55.81 54.57% | 51.95 6.91% | 21.94 57.77% | 27.92 27.26% | 72.57 159.89% | 94.86 30.71% | 19.60 79.34% | 36.07 84.07% | 31.10 13.77% | |
interest debt per share | 77.49 - | 81.85 5.62% | 58.42 28.63% | 82.49 41.21% | 121.48 47.27% | 109.96 9.48% | 95.73 12.94% | 56.59 40.89% | 92.63 63.68% | 112.74 21.72% | 149.62 32.71% | |
inventory turnover | 1.52 - | 1.51 1.20% | 1.49 1.36% | 1.15 22.42% | 1.20 4.32% | 1.26 5.14% | 1.10 13.23% | 1.34 22.37% | 1.33 1.16% | 1.32 0.22% | 1.24 6.69% | |
invested capital | 0.86 - | 0.67 22.82% | 0.40 39.83% | 0.41 1.86% | 0.50 22.81% | 0.37 25.26% | 0.25 32.49% | 0.13 47.28% | 0.20 47.62% | 304.95B 154,832,263,148,734.41% | 321.74B 5.51% | |
market cap | 356.41B - | 435.14B 22.09% | 395.14B 9.19% | 347.16B 12.14% | 464.24B 33.72% | 242.08B 47.85% | 516.39B 113.31% | 391.73B 24.14% | 303.54B 22.51% | 652.26B 114.89% | 661.01B 1.34% | |
net current asset value | 5.66B - | 14.18B 150.58% | 13.50B 4.83% | 27.65B 104.82% | 28.03B 1.36% | 42.97B 53.32% | 78.99B 83.83% | 87.75B 11.10% | 85.08B 3.05% | 89.85B 5.61% | 100.24B 11.57% | |
net debt to ebitda | 1.51 - | 1.20 20.17% | 0.81 33.02% | 0.92 14.14% | 1.27 38.23% | 0.72 43.43% | 0.03 95.44% | -0.19 683.20% | 0.22 216.43% | 0.53 136.58% | 0.00 99.21% | |
net income per share | 27.00 - | 33.93 25.64% | 39.33 15.92% | 41.36 5.16% | 40.36 2.42% | 48.32 19.71% | 91.05 88.45% | 45.20 50.36% | 32.90 27.20% | 54.16 64.62% | 59.81 10.43% | |
operating cash flow per share | 21.20 - | 30.12 42.11% | 56.02 85.99% | 33.37 40.44% | 27.68 17.03% | 74.77 170.10% | 56.81 24.02% | 85.61 50.69% | 40.74 52.42% | 41.56 2.00% | 67.34 62.04% | |
payables turnover | 2.68 - | 2.44 9.21% | 2.59 6.11% | 2.57 0.61% | 3.25 26.63% | 3.83 17.54% | 3.54 7.37% | 3.75 5.87% | 2.92 22.24% | 2.92 0.06% | 3.11 6.67% | |
receivables turnover | 2.98 - | 2.78 6.67% | 3.59 29.16% | 3.36 6.30% | 3.22 4.17% | 5.19 60.88% | 6.59 27.07% | 5.24 20.42% | 5.31 1.17% | 6.02 13.49% | 5.52 8.30% | |
research and ddevelopement to revenue | 0.00 - | 0.00 47.48% | 0.00 2.48% | 0.00 59.53% | 0.00 118.08% | 0.01 36.16% | 0.00 47.69% | 0.00 0.35% | 0.00 42.52% | 0.05 3,170.71% | ||
return on tangible assets | 0.13 - | 0.13 2.31% | 0.15 12.71% | 0.13 15.95% | 0.10 20.01% | 0.11 8.92% | 0.17 57.34% | 0.09 49.66% | 0.05 38.67% | 0.08 44.43% | 0.08 1.12% | |
revenue per share | 206.38 - | 233.66 13.22% | 250.57 7.24% | 276.49 10.34% | 328.14 18.68% | 388.06 18.26% | 419.12 8.00% | 398.79 4.85% | 420.18 5.37% | 495.04 17.81% | 544.31 9.95% | |
roe | 0.31 - | 0.28 8.10% | 0.27 2.34% | 0.21 24.37% | 0.17 17.94% | 0.17 1.08% | 0.24 44.45% | 0.11 55.71% | 0.07 33.35% | 0.11 48.05% | 0.11 0.41% | |
roic | 0.18 - | 0.18 0.84% | 0.19 9.93% | 0.15 23.81% | 0.12 18.41% | 0.13 5.24% | 0.11 11.42% | 0.10 14.15% | 0.06 35.53% | 0.21 235.09% | 0.24 12.51% | |
sales general and administrative to revenue | 0.02 - | 0.02 11.71% | 0.02 16.53% | 0.03 11.89% | 0.02 12.64% | 0.03 29.70% | 0.03 17.53% | 0.03 18.06% | 0.03 2.50% | 0.03 4.78% | ||
shareholders equity per share | 88.36 - | 120.80 36.72% | 143.38 18.69% | 199.36 39.04% | 237.08 18.92% | 286.90 21.01% | 374.27 30.45% | 419.43 12.07% | 458.12 9.23% | 509.39 11.19% | 560.26 9.99% | |
stock based compensation to revenue | -0.00 - | 0.00 106.47% | 0.00 - | |||||||||
tangible asset value | 43.29B - | 62.45B 44.28% | 74.22B 18.84% | 97.15B 30.90% | 107.85B 11.01% | 135.45B 25.59% | 188.09B 38.87% | 209.61B 11.44% | 229.30B 9.39% | 257.74B 12.40% | 284.08B 10.22% | |
tangible book value per share | 74.18 - | 106.91 44.12% | 126.82 18.62% | 165.81 30.75% | 184.07 11.01% | 231.16 25.59% | 321.01 38.87% | 357.73 11.44% | 391.39 9.41% | 439.94 12.41% | 487.42 10.79% | |
working capital | 21.62B - | 25.26B 16.80% | 25.84B 2.31% | 35.07B 35.74% | 33.22B 5.29% | 50.26B 51.30% | 91.58B 82.23% | 99.67B 8.83% | 100.52B 0.85% | 120.06B 19.45% | 124.80B 3.94% |
All numbers in INR (except ratios and percentages)